Patents by Inventor Rinat Abramovitch

Rinat Abramovitch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating and diagnosing metastatic liver cancer
    Patent number: 11246912
    Abstract: The present invention is directed to a method for treating or preventing cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an adropin stimulating agent. Further provided are a method and a kit for diagnosing or prognosing liver metastases in a subject.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: February 15, 2022
    Assignee: HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.
    Inventors: Rinat Abramovitch, Esther Goldlist
  • METHODS FOR TREATING AND DIAGNOSING METASTATIC LIVER CANCER
    Publication number: 20210008169
    Abstract: The present invention is directed to a method for treating or preventing cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an adropin stimulating agent. Further provided are a method and a kit for diagnosing or prognosing liver metastases in a subject.
    Type: Application
    Filed: August 30, 2018
    Publication date: January 14, 2021
    Inventors: Rinat ABRAMOVITCH, Esther GOLDLIST
  • Caspase-8 and inflammation, infection and wound healing
    Patent number: 8304384
    Abstract: The present invention relates to the regulatory role of caspase-8 in infection by intracellular pathogen, inflammation and wound healing.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: November 6, 2012
    Assignees: Yeda Research and Development Co., Ltd, Hadasit Medical Research Services and Development Ltd.
    Inventors: David Wallach, Rinat Abramovitch, Eitan Galun, Tehila Ben Moshe, Hila Barash
  • Facilitation of wound healing with CM101/GBS toxin
    Patent number: 6670337
    Abstract: The method of the present invention provides a means for protecting a patient, including a transplant patient, from reperfusion injury by administering CM101 or GBS toxin isolated from Group B &bgr;-hemolytic Streptococcus bacteria. The present invention also includes a method to protect a tissue or organ against reperfusion injury in a transplant patient.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: December 30, 2003
    Assignees: Yeda Reaearch and Development Co., Ltd., Vanderbilt University
    Inventors: Carl G. Hellerqvist, Michal Neeman, Barbara D. Wamil, Rinat Abramovitch
  • Facilitation of wound healing with CM101/GBS toxin
    Publication number: 20030212041
    Abstract: The method of the present invention provides a means of treating a patient having a wound, especially by minimizing scarring and accelerating wound healing, by administering CM101 or GBS toxin isolated from Group B &bgr;-hemolytic Streptococcus bacteria. Types of wounds that may be treated include surface and internal wounds. The method of the present invention also includes administration of CM101 or GBS toxin to surgery patients having tumors in order to facilitate wound healing and minimize the likelihood of tumor progression.
    Type: Application
    Filed: June 17, 2003
    Publication date: November 13, 2003
    Inventors: Carl G. Hellerqvist, Michal Neeman, Barbara D. Wamil, Rinat Abramovitch
  • Facilitation of wound healing with CM101/GBS toxin
    Publication number: 20030180331
    Abstract: The method of the present invention provides a means of treating a patient having a wound, especially by minimizing scarring and accelerating wound healing, by administering CM101 or GBS toxin isolated from Group B &bgr;-hemolytic streptococcus bacteria. The method of the present invention also includes administration of CM101 or GBS toxin to surgery patients having tumors in order to facilitate wound healing and minimize the likelihood of tumor progression.
    Type: Application
    Filed: March 24, 2003
    Publication date: September 25, 2003
    Inventors: Carl G. Hellerqvist, Michal Neeman, Barbara D. Wamil, Rinat Abramovitch
  • Facilitation of keloid healing with CM101/GBS toxin
    Patent number: 6569838
    Abstract: The present invention includes a means of treating a patient having a keloid. Specifically, the invention includes a method for excising the keloid and administering a GBS toxin isolated from Group B &bgr;-hemolytic Streptococcus bacteria.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: May 27, 2003
    Assignees: Vanderbilt University, Yeda Research & Development Ltd.
    Inventors: Carl G. Hellerqvist, Michal Neeman, Barbara D. Wamil, Rinat Abramovitch
  • Facilitation of wound healing with CM101/GBS toxin
    Patent number: 5858991
    Abstract: The method of the present invention provides a means of treating a patient having a wound, especially by minimizing scarring and accelerating wound healing, by administering CM101 or GBS toxin isolated from Group B .beta.-hemolytic streptococcus bacteria. The method of the present invention also includes administration of CM101 or GBS toxin to surgery patients having tumors in order to facilitate wound healing and minimize the likelihood of tumor progression.
    Type: Grant
    Filed: January 29, 1997
    Date of Patent: January 12, 1999
    Assignees: Vanderbilt University, Yeda Research & Development Co., Ltd.
    Inventors: Carl G. Hellerqvist, Michal Neeman, Barbara D. Wamil, Rinat Abramovitch